Credit Suisse’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-231,500
Closed -$4.65M 4369
2020
Q4
$4.65M Buy
231,500
+126,600
+121% +$2.65M ﹤0.01% 2152
2020
Q3
$2.56M Buy
+104,900
New +$2.45M ﹤0.01% 2244
2019
Q3
Sell
-299,500
Closed -$6.4M 4141
2019
Q2
$6.4M Buy
+299,500
New +$6.28M 0.01% 1584
2019
Q1
Sell
-477,500
Closed -$9.39M 4018
2018
Q4
$9.39M Buy
477,500
+462,200
+3,021% +$8.24M 0.01% 1187
2018
Q3
$271K Buy
+15,300
New +$298K ﹤0.01% 3567

Other funds holding EXEL

Credit Suisse's EXEL Position: Q1 2024 in Review

Credit Suisse increased its Exelixis (EXEL) stake by 2.1% in Q1 2024, buying an estimated $160K and bringing the position to 352,756 shares worth $8.37M. The position accounts for 0.01% of the portfolio, ranked #1006.

Credit Suisse first reported a position in EXEL in Q2 2013 and has held it in 44 quarters since. The position peaked at $23.6M in Q4 2017. 423 funds tracked by Wall St. Rank hold EXEL as of Q1 2024.

  • Credit Suisse held 352,756 shares of Exelixis worth $8.37M as of Q1 2024.
  • Credit Suisse bought 7,204 Exelixis shares in Q1 2024, an estimated $160K.
  • Exelixis made up 0.01% of Credit Suisse's portfolio in Q1 2024, its #1006 holding.
  • Credit Suisse first reported a position in Exelixis in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's Exelixis position peaked at $23.6M in Q4 2017.
  • 423 funds tracked by Wall St. Rank held Exelixis as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.